Clinical Research Informer

Gemini’s fall gives Disc a way around biotech’s IPO slump

Bio Pharma Dive

AUGUST 10, 2022

The biotech’s failed attempt to develop an eye disease drug has ended in a reverse merger that gives startup Disc Medicine a fast path to the public markets.

Medicine

Medicine Marketing Development Drugs

Amazing Brain Implant Gives a Voice to People Who Couldn’t Speak For Years

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 27, 2023

In two separate cases, scientists have successfully used brain implants and machine learning to give patients back their voice after theirs was taken; one by a stroke, the other a result of amyotrophic lateral sclerosis (ALS). There’s new hope for people who have lost their ability to speak.

Scientist

Scientist Clinical Trials Clinical Trials Clinical Research

BIOSECURE Act Gets Update, Gives US Drugmakers Until 2032 to Sever Ties with Chinese Biotechs

BioSpace

MAY 12, 2024

An updated draft of the BIOSECURE Act introduced on Friday would give U.S. drug manufacturers additional leeway for existing contracts with certain Chinese “companies of concern” until 2032.

Manufacturing

Manufacturing Drugs

Health Canada gives approval to Enhertu for breast cancer treatment

Pharmaceutical Technology

JANUARY 13, 2023

The post Health Canada gives approval to Enhertu for breast cancer treatment appeared first on Pharmaceutical Technology.

HR

HR Trials Engineer Clinical Trials

The PM Society – Giving Back

pharmaphorum

APRIL 22, 2024

The PM Society is dedicated to giving back to the community through various events and initiatives. Learn more about its mission and how you can get involved.

In refiling $16.5B Catalent buyout pitch, Novo gives FTC more time for review

Fierce Pharma

APRIL 5, 2024

billion buyout of contract manufacturing giant Catalent earlier this year, its parent company is giving antitrust officials more time for their review | After Novo Holdings pitched a $16.5 After Novo Holdings set the stage for a $16.5 billion buyout of Catalent in February, the companies have given the FTC extra time to review the deal.

Contract Manufacturing

Contract Manufacturing Manufacturing

Nestle gives up on peanut allergy treatment after sluggish sales

Bio Pharma Dive

SEPTEMBER 5, 2023

The FDA-approved therapy, called Palforzia, was little used, leading Nestle to abandon a business it had secured in a $2.6 billion deal three years ago.

Allergies

Allergies Sales FDA Approval

NABL follows rigorous process while giving accreditation to a drug testing laboratory: NABL CEO

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 20, 2023

The National Accreditation Board for Testing and Calibration Laboratories (NABL) follows a rigorous process while giving accreditation to a drug testing laboratory. It includes the scrutiny of application as well as quality management system (QMS) documents in accordance with ISO/IEC 17025:2017, informs N Venkateswaran, CEO, NABL.

Drugs

Drugs Clinical Trials Clinical Trials Clinical Research

Healthcare doesn’t give a damn about patients

World of DTC Marketing

JULY 20, 2022

The post Healthcare doesn’t give a damn about patients appeared first on World of DTC Marketing.com. Still, this is unacceptable in a country where we believe our healthcare is the best (it isn’t), where life expectancy is declining. Will the industry ever develop a conscience?

Packaging

Packaging Packaging Drugs Vaccination

Merck gives taxpayers the middle finger

World of DTC Marketing

OCTOBER 6, 2021

The post Merck gives taxpayers the middle finger. To quote a Senator from the past, “have you no shame?” ” The pharma industry is doing its best to prove to the American people that they are just another big business that is only concerned about profits. appeared first on World of DTC Marketing.com.

Clinical Trials

Clinical Trials Clinical Trials Allergies Trials

Abecma delay gives Carvykti a chance to catch up

pharmaphorum

NOVEMBER 21, 2023

Abecma delay gives Carvykti a chance to catch up Phil.Taylor Tue, 21/11/2023 - 10:44 Bookmark this

Acadia gives once-rejected Prader-Willi drug a second chance

Bio Pharma Dive

JUNE 14, 2023

The FDA last year turned back an approval request from the drug’s former developer, Levo Therapeutics. That biotech is now owned by Acadia, which will run a new study designed to boost its odds of success.

Drugs

Drugs Development

Adlai Nortye IPO gives old Novartis cancer drug new life

Bio Pharma Dive

SEPTEMBER 29, 2023

The biotech is using the proceeds to bankroll Phase 3 testing of a drug the Swiss pharma studied widely before selling it off for cheap a few years ago.

Drugs

Eisai gives first glimpse into Alzheimer’s drug launch

Bio Pharma Dive

FEBRUARY 6, 2023

In the month since its U.S. approval, Leqembi has had its first sale, its first prescription written and its first administration to a patient.

Sales

Sales Drugs

Give HCPs a proactive way to reach your field team: Add inbound

Bio Pharma Dive

MARCH 18, 2024

HCPs today want inbound channels for help when they need it. See how you can meet their preferences.

GSK gives Wave a lift with genetic medicine deal

Bio Pharma Dive

DECEMBER 14, 2022

A four-year agreement between the companies comes with $170 million in cash and equity for Wave, which in recent years has dealt with clinical setbacks.

Genetics

Genetics Medicine

MSD gives warning to UK ahead of $1.3bn facility work

pharmaphorum

OCTOBER 16, 2023

MSD gives warning to UK ahead of $1.3bn facility work Phil.Taylor Mon, 16/10/2023 - 08:12 Bookmark this

Freeline gives detailed look at hemophilia gene therapy results

Bio Pharma Dive

JULY 21, 2022

The London-based drugmaker is currently seeking a partner to continue development of the hemophilia B treatment, which has shown promise in testing but trails a rival therapy from CSL Behring and UniQure.

Gene Therapy

Gene Therapy Gene Development

A biotech startup gives Merck its next shot at Alzheimer’s

Bio Pharma Dive

AUGUST 9, 2022

Boston-based Cerevance uses samples of healthy and diseased human brain tissue to find new targets for central nervous system diseases.

FDA panel gives unanimous support to Leqembi

pharmaphorum

JUNE 10, 2023

FDA panel gives unanimous support to Leqembi Phil.Taylor Sat, 10/06/2023 - 16:07 Bookmark this

Back-to-back gene therapy approvals give Bluebird shot at survival

Bio Pharma Dive

SEPTEMBER 19, 2022

The FDA's clearances of Zynteglo and Skysona are a boost to Bluebird, and could help lift the research field after a series of setbacks. But selling the high-priced therapies will be a challenge.

Gene Therapy

Gene Therapy Gene Research

A cancer biotech’s collapse gives Neurogene a path to Wall Street

Bio Pharma Dive

JULY 18, 2023

The startup, a developer of gene therapies for brain diseases like Rett Syndrome, will bypass an IPO by merging with struggling cancer drugmaker Neoleukin.

Gene Therapy

Gene Therapy Gene Development

Merck gives €500k prize to pandemic early warning system

pharmaphorum

JULY 12, 2023

Merck gives €500k prize to pandemic early warning system Phil.Taylor Wed, 12/07/2023 - 09:13 Bookmark this

AstraZeneca gives up on Ionis’ RNA drug for heart disease

Bio Pharma Dive

SEPTEMBER 23, 2022

The British drugmaker decided the medicine, which works similarly to Novartis’s Leqvio, wasn’t potent enough to justify further testing.

RNA

RNA Medicine Drugs

FDA gives nod to BrainStorm for ALS trial after Phase III flop

Pharmaceutical Technology

APRIL 9, 2024

BrainStorm Cell Therapeutics has faced a few hurdles along the way towards the development of its lead candidate, NurOwn for ALS.

Trials

Trials Development

The Give Back: Introducing the New Intouch Philanthropy Program

Intouch Solutions

MAY 2, 2022

The Give Back is Intouch’s approach to – well – giving back. What are these three pillars of giving, we hear you ask? We encourage Intouchers to share causes they care about that parallel these three pillars with The Give Back’s leadership committee, so we can learn more and figure out ways to help.

‘Stiffness’ of cells could give early warning of cancer

pharmaphorum

APRIL 16, 2024

Researchers from the UK have developed an endoscopic device that uses 3D imaging to look at the stiffness of cells and could diagnose cancer earlier.

Development

Development Research

The Give Back Hosts Virtual Blood Drive

Intouch Solutions

FEBRUARY 17, 2023

This week, The Give Back , our philanthropy program, hosted a virtual blood drive in honor of Valentine’s Day where we encouraged all of our team members to pledge and give blood at local banks during the week. the virtual blood drive allows our employees to give blood locally and conveniently, wherever they live.

Doctors

Doctors Doctor

Mirati gives first look at KRAS drug combination in lung cancer

Bio Pharma Dive

NOVEMBER 8, 2021

Study results for Mirati's drug combined with Keytruda have been much anticipated, as the San Diego biotech aims to challenge Amgen and its rival KRAS-blocking drug Lumakras.

Drugs

The Brain Cells That Give You Motion Sickness May Have Been Identified

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 24, 2023

If the idea of driving down a winding road makes you feel queasy, spare a thought for the mice employed in a new study, which sought to pinpoint the brain cells responsible for motion sickness. Unsuspecting mice were plopped in a plastic tube, strapped onto a rotating spinner, and sent for a ride, so researchers […]

Research

Research Clinical Trials Clinical Trials Clinical Research

Roche stops giving Huntington's disease drug in closely watched study

Bio Pharma Dive

MARCH 23, 2021

A disappointing recommendation from outside data reviewers raises doubts about the DNA-targeting drug's benefits and puts pressure on Roche's partner, Ionis Pharmaceuticals.

DNA

DNA Drugs

CRUK gives £58m funding for clinician scientist training

pharmaphorum

APRIL 5, 2024

Cancer Research UK has announced a £58.7m initiative to train more doctors as clinician scientists that can contribute to research into new cancer treatments

Scientist

Scientist Doctors Doctor Research

Adverum cuts jobs, restructures to give eye gene therapy another shot

Bio Pharma Dive

JULY 7, 2022

A year after reporting side effects “not seen before in ocular gene therapy” in a clinical trial, the biotech is eliminating 38% of its workforce to save cash while it runs a new study.

Gene Therapy

Gene Therapy Gene Clinical Trials Clinical Trials

Investigator Meetings: Tips to Give Your Meetings Extra Impact

Imperical Blog

NOVEMBER 14, 2023

It’s the… The post Investigator Meetings: Tips to Give Your Meetings Extra Impact appeared first on Imperial Clinical Research Services Blog. Investigator meetings (IMs) are ripe opportunities for sponsors and/or their CRO partners to get sites excited about the study.

Clinical Research

Clinical Research Research Branding

A startup plans an IPO to give a shelved Lilly drug another shot

Bio Pharma Dive

OCTOBER 19, 2022

Acrivon Therapeutics is looking to fund a development approach it claims could improve the prospects of a cancer drug Lilly scrapped after testing it in clinical trials.

Clinical Trials

Clinical Trials Clinical Trials Drugs Trials

Giving the Gift of Hope: Participating in Clinical Trials During the Holiday Season

My Local Study

DECEMBER 4, 2023

The holiday season is a time of joy, giving, and reflection. While many are busy shopping for gifts and planning festive gatherings, there’s an opportunity to give a different kind of gift – the gift of hope through participation in clinical trials.

Clinical Trials

Clinical Trials Clinical Trials Trials Clinical Research

Can ChatGPT give women accurate advice on breast cancer?

Medical Xpress

APRIL 10, 2023

ChatGPT, the AI chatbot everyone is talking about, can often give reliable answers to questions about breast cancer, a new study finds. But it's not yet ready to replace your physician.

Radiology

U.S. House Votes to Give FDA More Power Over Accelerated Approvals

BioSpace

JUNE 9, 2022

The House of Representatives voted on a bill that would give the U.S. Food and Drug Administration more power to ensure biopharma companies run large follow-up trials to confirm accelerated approvals.

Trials

Trials Drugs

Excision gives first look at gene editing therapy for HIV

Bio Pharma Dive

OCTOBER 25, 2023

The study results, while only from three participants, offer a glimpse at how one of the few in vivo CRISPR therapies in U.S. human testing is working.

Gene Editing

Gene Editing In-Vivo Gene

Test could give early warning of motor neuron disease

pharmaphorum

MARCH 28, 2024

Scientists say a test for motor neuron disease, based on an aptamer for biomarker TDP-43 in brain tissue, could detect at-risk people before symptoms develop.

Scientist

Scientist Development

Detailed Lilly data give mixed picture of Alzheimer's drug's benefit

Bio Pharma Dive

MARCH 13, 2021

Highly anticipated results from a Phase 2 study of donanemab showed treatment slowed disease progression, but mixed data on other measures could temper optimism in its potential.

Drugs

FDA gives speedy approval to another Duchenne drug

Bio Pharma Dive

AUGUST 12, 2020

Viltepso, from Japanese drugmaker NS Pharma, is approved to treat the same subset of Duchenne patients as Sarepta's Vyondys 53.

Drugs

Pharma needs to give the boot to McKinsey

World of DTC Marketing

FEBRUARY 16, 2021

The post Pharma needs to give the boot to McKinsey appeared first on World of DTC Marketing.com. Their MBA’s with spreadsheets and PowerPoint’s have been the weight to bring and industry down. I love this industry so much but am I the only one who keeps yelling that patients need our help more than Wall Street needs profits?

Sales

Sales Pharma Companies Drugs Marketing

Giving Thanks for Scientific Advances and COVID-19 Relief

BioSpace

NOVEMBER 24, 2021

With the Thanksgiving holiday upon us, BioSpace felt it was important to give thanks for some of the positive things that have happened this year. And there are many!

Gemini’s fall gives Disc a way around biotech’s IPO slump

Amazing Brain Implant Gives a Voice to People Who Couldn’t Speak For Years

Trending Sources

BIOSECURE Act Gets Update, Gives US Drugmakers Until 2032 to Sever Ties with Chinese Biotechs

Health Canada gives approval to Enhertu for breast cancer treatment

The PM Society – Giving Back

In refiling $16.5B Catalent buyout pitch, Novo gives FTC more time for review

Nestle gives up on peanut allergy treatment after sluggish sales

NABL follows rigorous process while giving accreditation to a drug testing laboratory: NABL CEO

Healthcare doesn’t give a damn about patients

Merck gives taxpayers the middle finger

Abecma delay gives Carvykti a chance to catch up

Acadia gives once-rejected Prader-Willi drug a second chance

Adlai Nortye IPO gives old Novartis cancer drug new life

Eisai gives first glimpse into Alzheimer’s drug launch

Give HCPs a proactive way to reach your field team: Add inbound

GSK gives Wave a lift with genetic medicine deal

MSD gives warning to UK ahead of $1.3bn facility work

Freeline gives detailed look at hemophilia gene therapy results

A biotech startup gives Merck its next shot at Alzheimer’s

FDA panel gives unanimous support to Leqembi

Back-to-back gene therapy approvals give Bluebird shot at survival

A cancer biotech’s collapse gives Neurogene a path to Wall Street

Merck gives €500k prize to pandemic early warning system

AstraZeneca gives up on Ionis’ RNA drug for heart disease

FDA gives nod to BrainStorm for ALS trial after Phase III flop

The Give Back: Introducing the New Intouch Philanthropy Program

‘Stiffness’ of cells could give early warning of cancer

The Give Back Hosts Virtual Blood Drive

Mirati gives first look at KRAS drug combination in lung cancer

The Brain Cells That Give You Motion Sickness May Have Been Identified

Roche stops giving Huntington's disease drug in closely watched study

CRUK gives £58m funding for clinician scientist training

Adverum cuts jobs, restructures to give eye gene therapy another shot

Investigator Meetings: Tips to Give Your Meetings Extra Impact

A startup plans an IPO to give a shelved Lilly drug another shot

Giving the Gift of Hope: Participating in Clinical Trials During the Holiday Season

Can ChatGPT give women accurate advice on breast cancer?

U.S. House Votes to Give FDA More Power Over Accelerated Approvals

Excision gives first look at gene editing therapy for HIV

Test could give early warning of motor neuron disease

Detailed Lilly data give mixed picture of Alzheimer's drug's benefit

FDA gives speedy approval to another Duchenne drug

Pharma needs to give the boot to McKinsey

Giving Thanks for Scientific Advances and COVID-19 Relief

Stay Connected